HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steve Bender Selected Research

AG-012986

4/2008Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Steve Bender Research Topics

Disease

4Neoplasms (Cancer)
01/2013 - 04/2008
1Colorectal Neoplasms (Colorectal Cancer)
01/2013
1Retinoblastoma (Glioblastoma, Retinal)
04/2008

Drug/Important Bio-Agent (IBA)

12- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA
01/2013
1Biomarkers (Surrogate Marker)IBA
01/2013
1Pharmaceutical PreparationsIBA
09/2011
1Phosphotransferases (Kinase)IBA
09/2011
1tyrosine receptor (receptor, tyrosine)IBA
09/2011
1CrizotinibIBA
09/2011
1Cadherins (E-Cadherin)IBA
11/2010
1PF-03732010 monoclonal antibodyIBA
11/2010
1Monoclonal AntibodiesIBA
11/2010
1Biological ProductsIBA
11/2010
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
11/2010
1AG-012986IBA
04/2008

Therapy/Procedure

1Therapeutics
11/2010